Literature DB >> 19179972

Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia.

Beata Galińska1, Agata Szulc, Eugeniusz Tarasów, Bozena Kubas, Wojciech Dzienis, Andrzej Czernikiewicz, Jerzy Walecki.   

Abstract

BACKGROUND: The duration of untreated psychosis (DUP) is a factor associated with the natural course of schizophrenia and an independent predictor of treatment outcome. Recent studies focus on the effects of DUP on the functioning of the nervous system, but the findings are inconsistent. As proton magnetic resonance spectroscopy (1H-MRS) enables the assessment of signals from chemical compounds in vivo, it seems a useful tool to explore this problem. MATERIAL/
METHODS: In this study the relationships between DUP and 1H-MRS measurements were investigated. Thirty patients with first-episode schizophrenia and 19 controls were examined. Median DUP was 10 weeks. Voxels were positioned in the following regions of interest: the left frontal lobe, left temporal lobe, and left thalamus. The ratios of N-acetylaspartate (NAA), choline-containing compounds (Cho), myoinositol (mI), and glutamate/glutamine/GABA complex (Glx) to creatine (Cr) and the non-suppressed water signal were determined.
RESULTS: There were no significant differences between the whole group of patients and healthy subjects for the analyzed metabolite ratios in any region of interest. No differences were found between the groups of patients with short and long DUP and controls. No significant correlation was observed between DUP and metabolite ratios.
CONCLUSIONS: The results of the study may suggest that the relatively short DUP does not influence brain metabolism in first-episode schizophrenia.

Entities:  

Mesh:

Year:  2009        PMID: 19179972

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  22 in total

Review 1.  A review of altered biochemistry in the anterior cingulate cortex of first-episode psychosis.

Authors:  L Squarcina; J A Stanley; M Bellani; C A Altamura; P Brambilla
Journal:  Epidemiol Psychiatr Sci       Date:  2017-01-20       Impact factor: 6.892

Review 2.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

Review 3.  Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.

Authors:  Eline M P Poels; Lawrence S Kegeles; Joshua T Kantrowitz; Daniel C Javitt; Jeffrey A Lieberman; Anissa Abi-Dargham; Ragy R Girgis
Journal:  Schizophr Res       Date:  2014-01-11       Impact factor: 4.939

Review 4.  Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.

Authors:  Anouk Marsman; Martijn P van den Heuvel; Dennis W J Klomp; René S Kahn; Peter R Luijten; Hilleke E Hulshoff Pol
Journal:  Schizophr Bull       Date:  2011-07-11       Impact factor: 9.306

5.  GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression.

Authors:  Jong H Yoon; Richard J Maddock; Ariel Rokem; Michael A Silver; Michael J Minzenberg; J Daniel Ragland; Cameron S Carter
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

6.  1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage.

Authors:  Liat Ben Sira; Elka Miller; Moran Artzi; Aviva Fattal-Valevski; Shlomi Constantini; Dafna Ben Bashat
Journal:  Pediatr Radiol       Date:  2009-10-22

Review 7.  T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.

Authors:  Bethany K Bracken; Elizabeth D Rouse; Perry F Renshaw; David P Olson
Journal:  Psychiatry Res       Date:  2013-06-12       Impact factor: 3.222

8.  Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis.

Authors:  Shima Shakory; Jeremy J Watts; Sina Hafizi; Tania Da Silva; Saad Khan; Michael Kiang; R Michael Bagby; Sofia Chavez; Romina Mizrahi
Journal:  Neuropsychopharmacology       Date:  2018-07-28       Impact factor: 7.853

9.  Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia.

Authors:  A D Stan; S Ghose; C Zhao; K Hulsey; P Mihalakos; M Yanagi; S U Morris; J J Bartko; C Choi; C A Tamminga
Journal:  Mol Psychiatry       Date:  2014-06-10       Impact factor: 15.992

Review 10.  Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.

Authors:  E M P Poels; L S Kegeles; J T Kantrowitz; M Slifstein; D C Javitt; J A Lieberman; A Abi-Dargham; R R Girgis
Journal:  Mol Psychiatry       Date:  2013-10-29       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.